Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rx Imports: House Language May Be Preferred By Industry In Conference

Executive Summary

Brand name pharmaceutical companies could end up having to support the House drug import provisions in the Agriculture Appropriations bill as a way of avoiding a change to the Food, Drug & Cosmetic Act allowing for the importation of drugs.

You may also be interested in...



Merck Chairman Gilmartin Named To Bush's HHS Transition Advisory Team

Merck Chairman Ray Gilmartin is one of 19 outside health advisors on President-elect George W. Bush's HHS transition team.

Merck Chairman Gilmartin Named To Bush's HHS Transition Advisory Team

Merck Chairman Ray Gilmartin is one of 19 outside health advisors on President-elect George W. Bush's HHS transition team.

Senate Rx Import Plan Has Administration Support - If Funding Is Sufficient

FDA estimates that it will need $23 mil. in new appropriations to set up a system to oversee pharmaceutical importation under the approach included in the Senate version of the agriculture appropriations bill.

Related Content

UsernamePublicRestriction

Register

OM007466

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel